GK921
CAS: 1025015-40-0
Ref. 3D-ARB01540
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
GK921 is a drug candidate that inhibits the PD-1 pathway. It has been shown to inhibit tumor growth in xenograft models of cancer by inducing autophagy and inhibiting cell proliferation. GK921 was found to be effective in treating mouse models of cancer with radiation therapy and lysine residues, which are predictive biomarkers for efficacy. The drug also has inhibitory effects on mammalian cells through the inhibition of growth factor signaling pathways. GK921 is currently being studied in clinical trials as a treatment for cancer patients with risk groups such as lung adenocarcinoma and non-small cell lung cancer.
Chemical properties
Technical inquiry about: 3D-ARB01540 GK921
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
